Hi Richard,
Not the biggest fan of this company. Revenue has dropped YoY for the past three years from $4.4M in 2018 to only 1.4M over the past twelve months. It shows a profit, but that is a reaulst of a one time gain and it is actually generating negative operating income. This was a play on the COVID-19 hype and testing but it has yet to demonstrate that this has turned into a legit business model for them.
As you mentioned, it made a few acquisitions recently but unlike what many companies do, it has not revealed anything in terms of the financials of the companies it is acquiring. So it is a black box in terms of how it will add to the company's top and bottom lines. Looks like it will have to be a wait and see situation as investors are unlikely to get any details until quarterly results. The upcoming quarter will be a big one, because it should somewhat demonstrate its business model around covid-19 testing. So in theory, we should see a meaningful jump in revenue - that would be a good thing. If not, then it would be hard for me to justify jumping into it.
Mat